

1. (4r)-4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)(1,3,4)thiadiazol-5-yl)methyl)-2-pyrrolidinone
2. 2-pyrrolidinone, 4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)-1,3,4-thiadiazol-5-yl)methyl)-, (4r)-
1. 1294000-61-5
2. Padsevonil [inn]
3. Padsevonil [usan]
4. Ucb0942
5. Ucb-0942
6. Ucb1415943-000
7. 0r1hn52k0n
8. Ucb-1415943-000
9. (4r)-4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)(1,3,4)thiadiazol-5-yl)methyl)pyrrolidin-2-one
10. (4r)-4-(2-chloro-2,2-difluoroethyl)-1-[[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl]pyrrolidin-2-one
11. 2-pyrrolidinone, 4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)-1,3,4-thiadiazol-5-yl)methyl)-, (4r)-
12. Padsevonil [jan]
13. Padsevonil (jan/usan)
14. Padsevonil [who-dd]
15. Unii-0r1hn52k0n
16. Schembl1672843
17. Chembl4297521
18. Ex-a5541
19. Who 10384
20. Db14977
21. Hy-109009
22. Cs-0030507
23. D11842
24. Q27237119
25. (4r)-4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)(1,3,4)thiadiazol-5-yl)methyl)-2-pyrrolidinone
| Molecular Weight | 432.8 g/mol |
|---|---|
| Molecular Formula | C14H14ClF5N4O2S |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 6 |
| Exact Mass | 432.0446154 g/mol |
| Monoisotopic Mass | 432.0446154 g/mol |
| Topological Polar Surface Area | 88 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 572 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)